female pattern hair loss
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1, Ages 18-45, Sinclair II,III non-menopausal female pattern hair loss 2. Female patients with normal endocrinology, thyroid function and antibodies, hemoglobin, serum iron, ferritin and gynecologic ultrasound, and regular menstruation; 3. No topical use of hair growth drugs and other topical treatments within 3 months prior to treatment; 4. No systematic use of hair-generating drugs within 3 months prior to treatment; 5.have good compliance, can regularly participate in the interview.
Exclusion criteria
Exclusion criteria: 1, pregnant or lactating women, menopausal women, menstrual disorders; 2, other types of hair loss,such as alopecia areata, hair loss caused by ringworm; 3, severe systemic disease, anemia,low blood pressure, history of thyroid, polycystic ovaries, or elevated blood potassium; 4. Scalp hair follicles have atrophied so that hair cannot be generated; 5, can not be prescribed regularly, so that it is impossible to judge the efficacy or incomplete data 6. Infection exists in the area of microneedle acupuncture; 7, abnormal clotting function; 8, allergic to the test drug and its ingredients; 9. Researchers who are participating in other clinical trials; 10. The investigator considers it inappropriate to participate in this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hair density and hair shaft diameter under dermatoscope; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sinclair's stage change ; 7-point global-assessment scale;hair shedding score;the women's androgenetic alopecia quality of life questionnaire;patients' satisfaction; | — |
Countries
China
Contacts
Beijing Friendship Hospital,Capital Medical University